ReviewGlobal challenges (Hoboken, NJ)2025

Gadolinium-Based Contrast Agents (GBCAs) for MRI: A Benefit-Risk Balance Analysis from a Chemical, Biomedical, and Environmental Point of View.

Angelo Scarciglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.